Considerations for CPX-351 in Acute Myeloid Leukemia
2 Visualizzazioni
• 07/04/23
0
0
Incorporare
administrator
Iscritti
Expert panelists Eunice Wang, MD; Harry Erba, MD, PhD; Alexander E. Perl, MD; and Jorge E. Cortes, MD, identify important considerations when treating acute myeloid leukemia with CPX-351, such as its toxicity profile and patient stratification.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti